The Latest Analyst Ratings for Enanta Pharma
Portfolio Pulse from Benzinga Insights
Enanta Pharma (NASDAQ:ENTA) has received mixed analyst ratings in the last quarter, with 2 bullish, 1 somewhat bullish, and 3 indifferent ratings. The average price target is $34.33, indicating potential upside from the current price of $12.47. However, this average has decreased by 28.48% from the previous target of $48.00.
September 19, 2023 | 4:00 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Mixed analyst ratings and a decreased price target could lead to uncertainty for Enanta Pharma.
The mixed analyst ratings indicate differing opinions on the stock's potential, which could lead to uncertainty among investors. Additionally, the decrease in the average price target suggests that analysts have lowered their expectations for the stock, which could negatively impact investor sentiment.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100